C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) G01N 33/53 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2340721
The present invention provides the sequence of a cell matrix receptor specific for the Cys-Ser-Val-Thr-Cys-Gly (SEQ ID NO:1) region of thrombospondin. Also provided are purification, cloning and expression methods. The receptor protein is useful in numerous diagnostic, prophylactic and therapeutic areas.
La présente invention concerne la séquence d'un récepteur matriciel de cellule, spécifique de la région Cys-Ser-Val-Thr-Cys-Gly (SEQ ID NO:1) de la thrombospondine. L'invention concerne également la purification, le clonage et des procédés d'expression. La protéine réceptrice est utilisée dans de nombreux domaines diagnostiques, prophylactiques et thérapeutiques.
Tuszynski George
Williams Taffy
Inkine Pharmaceutical Company Inc.
Mccarthy Tetrault Llp
Philadelphia Health And Education Corporation
LandOfFree
Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1431022